Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Dental health education (345)
- Oral health (338)
- Pamphlet (296)
- Brochure (294)
- Leaflet (247)
-
- Booklet (221)
- Clinical Trials as Topic (88)
- Antineoplastic Agents (86)
- Child (86)
- Children (84)
- Radiotherapy (76)
- Breast Neoplasms (65)
- Dental habits (64)
- Tooth loss (64)
- Dental nutrition (58)
- History and medicine (54)
- Meetings (54)
- Ohio Academy of Medical History (54)
- Programs (54)
- UNECOM (52)
- Dental visits (49)
- Fluoride (49)
- University of New England College of Osteopathic Medicine (49)
- UNE (48)
- University of New England (48)
- Sweets (46)
- NECOM (41)
- Plaque (41)
- New England College of Osteopathic Medicine (40)
- Nutrition (36)
- Publication Year
- Publication
-
- Patient Dental Health Education Brochures (352)
- OncoLog MD Anderson's Report to Physicians (All issues) (274)
- William F. Bergen, D.O. Collection (66)
- Annual Conference Programs (54)
- Philadelphia Journal of Osteopathy (37)
-
- Obstetrics: The Science and The Art, by Charles D. Meigs, M.D. (29)
- Gene Yonuschot, Ph.D. Collection (10)
- Newsletter: A Report to Physicians of Texas (10)
- Jefferson Medical College Theses (9)
- Jefferson Nursing Oral Histories (9)
- John McPartland, D.O. Collection (8)
- Archives (4)
- Carmen Pettapiece, D.O. Scrapbooks (4)
- Posters: Jefferson History (4)
- Osteopathic Medicine (3)
- Histories (2)
- Interview Sessions (2)
- Medical Student and Faculty Lecture Notes (2)
- University of Western Ontario Medical Journal (2)
- 0064: Marshall University Oral History Collection (1)
- Books (1)
- College and Clinical Record (1)
- CwiC Posters (1)
- Director's Office Records: Ernst Bertner and R. Lee Clark (1)
- Interview Chapters (1)
- Jefferson History Books (1)
- Manuscript Collection (1)
- Manuscripts and Journals (1)
- Posters (1)
- Syracuse Unbound (1)
Articles 1 - 30 of 894
Full-Text Articles in Medicine and Health Sciences
New England Osteopathic Association: Constitution, New England Osteopathic Association
New England Osteopathic Association: Constitution, New England Osteopathic Association
John McPartland, D.O. Collection
Constitution of the New England Osteopathic Association organized in Boston January 28, 1905.
Vermont Osteopathic Association: Address Regarding Basic Science Bill, Unknown
Vermont Osteopathic Association: Address Regarding Basic Science Bill, Unknown
John McPartland, D.O. Collection
An address given by a member of the Vermont Osteopathic Association regarding the Vermont State Basic Science Bill.
Vermont State Association Of Osteopathic Physician And Surgeons Inc.: Correspondence Soliciting New D.O.S To Vermont, Vermont State Association Of Osteopathic Physicians And Surgeons Inc.
Vermont State Association Of Osteopathic Physician And Surgeons Inc.: Correspondence Soliciting New D.O.S To Vermont, Vermont State Association Of Osteopathic Physicians And Surgeons Inc.
John McPartland, D.O. Collection
A letter from the Vermont State Association of Osteopathic Physicians and Surgeons, Inc. soliciting D.O.s to move to Vermont.
Antibiotic Production Of Facultative Anaerobic Bacteria From Soil Isolates, Cierra Paaaina-Daquioag, Debra Kerr
Antibiotic Production Of Facultative Anaerobic Bacteria From Soil Isolates, Cierra Paaaina-Daquioag, Debra Kerr
Undergraduate Research Symposium Posters
In nature, antibiotics are produced by organisms to deter and possibly communicate with other organisms. The use of antibiotics to treat infections revolutionized medicine, but bacteria and fungal pathogens become resistant due to the overuse of these medications. A potential solution is to search for novel antibiotics produced by soil bacteria. Bacteria gene expression patterns, including antibiotic production, are different under aerobic and anaerobic conditions. The objective of this research project was to identify soil bacteria that produce antibiotics that inhibit the growth of benign relatives of the ESKAPE pathogens under aerobic and anaerobic conditions. A secondary objective was to …
Regarding Aoa, Undated, New England Foundation For Osteopathic Medicine
Regarding Aoa, Undated, New England Foundation For Osteopathic Medicine
William F. Bergen, D.O. Collection
Report from NEFOM on the effort to create an Osteopathic College at St. Francis College in Biddeford, Maine. The report discusses AOA accreditation and the role of St. Francis College.
Nefom Brochure, Undated, New England Foundation For Osteopathic Medicine
Nefom Brochure, Undated, New England Foundation For Osteopathic Medicine
William F. Bergen, D.O. Collection
No abstract provided.
Speech, Undated, William Bergen D.O.
Speech, Undated, William Bergen D.O.
William F. Bergen, D.O. Collection
Speech describing the history of osteopathic medicine as well as the contemporary state of the profession and osteopathic education.
Working Paper For A Proposed New England College Of Osteopathic Medicine, Undated, New England College Of Osteopathic Medicine
Working Paper For A Proposed New England College Of Osteopathic Medicine, Undated, New England College Of Osteopathic Medicine
William F. Bergen, D.O. Collection
A white paper outlining the plan for a New England College of Osteopathic Medicine.
New England College Of Osteopathic Medicine Biddeford, Maine, Undated, Unknown
New England College Of Osteopathic Medicine Biddeford, Maine, Undated, Unknown
William F. Bergen, D.O. Collection
This report details the need for an Osteopathic medical school in New England.
Osteopathic Medical Education For New England, Undated, New England Foundation For Osteopathic Medicine
Osteopathic Medical Education For New England, Undated, New England Foundation For Osteopathic Medicine
William F. Bergen, D.O. Collection
Booklet created by the New England Foundation for Osteopathic Medicine (NEFOM) discussing the need for Osteopathic Physicians and therefore a college of Osteopathic Medicine in New England.
Oncolog, Volume 63, Number 08, August 2018, Angie N. Meus, Joe Munch, Bryan Tutt
Oncolog, Volume 63, Number 08, August 2018, Angie N. Meus, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- High-Dose Radiation Therapy for Pancreatic Cancer: trial tests whether radiomodulating agent GC4419 can enable higher doses of stereotactic body radiation therapy
- Image-Guided Cordotomy for Cancer Pain: Computed tomography-guided cordotomy relieves cancer-related refractory pain
- Esophageal, Pharyngoesophageal Reconstruction: Advanced surgical techniques restore digestive continuity
- Therapy Preserves Swallowing Function: New trial tests different swallowing therapy regimens for head and neck cancer patients undergoing radiation therapy
- OncoLog Says Farewell
Oncolog, Volume 63, Number 07, July 2018, Sarah Bronson, Bryan Tutt
Oncolog, Volume 63, Number 07, July 2018, Sarah Bronson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- FGFR Inhibition for Bladder Cancer: Erdafitinib has favorable response rate in advanced bladder cancers, including those that do not respond to immunotherapy
- INBRIEF: Targeted Therapies Matched to Tumor-Specific Mutations Prolong Survival
- Managing High-Risk Breast Lesions: Strong provider recommendation for preventive therapy increases its use in women with lobular carcinoma in situ, atypical hyperplasia
- Aerosolized Gemcitabine for Pulmonary Metastases: Clinical trials tests novel chemotherapy delivery system for patients with lung metastases from osteosarcoma or other solid tumors
- HOUSE CALL: What the national Cancer Institute Does- Resources for cancer patients, caregivers, physicians, researchers
Oncolog, Volume 63, Number 05-06, May - June 2018, Joe Munch, Sunita Patterson, Bryan Tutt
Oncolog, Volume 63, Number 05-06, May - June 2018, Joe Munch, Sunita Patterson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Breast Cancer Treatment without Surgery: New approach may let certain breast cancer patients who respond to systemic therapy forgo surgery
- INBRIEF: Targeted Drug BLU-667 Shows Promise against Solid Tumors with RET Alterations
- Diet May Improve Gut Microbiome in Colorectal Cancer Survivors: Trial tests whether adding beans to diet affects markers of cancer risk, metabolic health
- TRK Inhibition Shows Activity in Solid Tumors: Early results of clinical trials for adult, pediatric patients with NTRK gene fusions show promise
- HOUSE CALL: Preparing for Natural Disasters-People with cancer or other chronic illnesses should take extra precautions
Oncolog, Volume 63, Number 04, April 2018, Joe Munch, Bryan Tutt, Sarah Bronson
Oncolog, Volume 63, Number 04, April 2018, Joe Munch, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Hunger Training Helps Manage Weight, May Reduce Cancer Risk: Clinical Trial tests weight loss strategy to reduce cancer risk in obese participants
- Re-Irradiation for Recurrent Head and Neck cancer: Stereotactic techniques enable re-irradiation of unresectable tumors
- Dermoscopy for Early Detection of Melanoma. Other Skin Cancers: MD Anderson physicians train clinicians in underserved areas to use dermoscopy, which can help avoid unnecessary biopsy
- HOUSE CALL: Alcohol-Related cancers-Drinking alcohol increases risk of several types of cancer
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
- INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
- Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
- Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
- HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening
Oncolog, Volume 63, Number 02, February 2018, Sarah Bronson, Bryan Tutt
Oncolog, Volume 63, Number 02, February 2018, Sarah Bronson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Radiation Therapy for Liver Cancer: Clinical trials expand treatment options for patients with primary liver cancer
- Proton Therapy for Breast Cancer May Avoid Heart Damage: Trial compares cardiotoxicity of proton-and photon-based radiation therapy to the breast/chest wall and lymph nodes
- New targeted Therapies for Leukemia: New treatments target CD123, BCL2 proteins in acute myelogenous leukemia, blastic plasmacytoid dendritic cell neoplasm
- HOUSE CALL: Supportive Care for Cancer Patients- Supportive care treats the whole patient, not just the cancer
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
- Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
- Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
- HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
- USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship
Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 11-12, November - December 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients.
- Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners
- HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these risks
Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt
Oncolog, Volume 62, Number 10, October 2017, Sarah Bronson, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Organ-Sparing Therapy for Esophageal Cancer: Endoscopic surgery, ablation treat early-stage cancer, dysplasia while avoiding esophagectomy.
- INBRIEF: Surgeons Perform Unique Allogeneic Soft Tissue Transplant Between Identical Twins
- Advances in Breast Reconstruction: New reconstruction techniques increase breast cancer surgical options, improve cosmetic outcomes.
- HOUSE CALL: Facing the Financial Burden of Cancer Treatment-Talking to care team, seeking out resources are important steps in managing cancer-related financial stress
- INBRIEF: Proton Therapy plus Chemotherapy Shows Promise in Lung Cancer Trial
Oncolog, Volume 62, Number 09, September 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 09, September 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Laser Interstitial Thermal Therapy for Spinal Metastases: Laser technique may be alternative to open surgery prior to stereotactic radiation therapy for metastases adjacent to the spinal cord.
- Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Cancer: Trial combines atezolizumab with targeted or cytotoxic agents for patients with anaplastic or poorly differentiated thyroid cancer.
- A New era in Follicular Lymphoma: Newly approved drugs, clinical trials represent shift from cytotoxic to targeted and immunotherapeutic agents.
- HOUSE CALL: Understanding Clinical Trials- Trials provide access to new cancer treatments
- INBRIEF: Repeat Surgery for Close Margins May Be Unnecessary for DCIS Patients Receiving Radiation Therapy
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
- Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
- Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
- HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
- Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
- Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
- HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
OncoLog MD Anderson's Report to Physicians (All issues)
- Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
- Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
- Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
- HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
- Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
- Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
- HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy
Oncolog, Volume 62, Number 03, March 2017, Bryan Tutt, Joe Munch, Brandon C. Strubberg
Oncolog, Volume 62, Number 03, March 2017, Bryan Tutt, Joe Munch, Brandon C. Strubberg
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Glioblastoma: Clinical trials test innovative immunotherapy approaches against brain tumors.
- Virus-Specific T Cells Treat Posttransplant Infections: Banked T cells offer "off-the-shelf" therapy for patients with BK virus, JC virus, Cytomegalovirus infections after stem cell transplant.
- Intensity-Modulated Proton Therapy for Oropharyngeal Cancer: Clinical trial compares outcomes of intensity-modulated proton therapy, standard radiation therapy.
- HOUSE CALL: Lung Cancer Screening-Low-dose computed tomography can detect lung cancer early
Oncolog, Volume 62, Number 02, February 2017, Jill Deisigne-Russell, Christina Bennett, Laura Russell
Oncolog, Volume 62, Number 02, February 2017, Jill Deisigne-Russell, Christina Bennett, Laura Russell
OncoLog MD Anderson's Report to Physicians (All issues)
- Fallopian Tube Removal May Reduce Ovarian Cancer Risk: Alternative approach to prophylactic surgery for women with BRCA mutations averts early menopause.
- Highlights from the 2016 San Antonio Breast Cancer Symposium: MD Anderson researchers present findings regarding diagnosis, staging, treatment.
- INBRIEF: Locoregional Restaging of Newly Diagnosed Breast Cancer with Mammography and Ultrasonography May Help Detect Additional Lesions
- HOUSE CALL: Stem Cell Transplant Terms: Helpful definitions for patients and families
- USEFUL RESOURCES: Algorithms for Managing Treatment-Related Conditions
Triple Triumph: Three Women In Medicine
Triple Triumph: Three Women In Medicine
Syracuse Unbound
Triple triumph: Three women in medicine is the story of three physicians.
Three physicians, all women, each perceived serious unmet needs in their fields, and envisioned imaginative approaches to meeting those needs. Each encountered resistance, discouragement, and obstruction from the traditional, male-dominated departments in which they worked. These powerful pioneers, undeterred, created programs that earned the highest levels of national distinction and acclaim. Their work and their names are now legendary—in geriatric medicine, in the treatment of breast cancer, and in diabetes research and treatment. Their stories differ, but the commonalities help us understand why constructive change is often so …
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
OncoLog MD Anderson's Report to Physicians (All issues)
- Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
- Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
- INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
- HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
- USEFUL RESOURCES: Resources to Aid Referring Physicians
Oncolog, Volume 61, Number 11-12, November - December 2016, Brandon C. Strubberg, Sarah Bronson, Stephanie Deming, E Nielsen
Oncolog, Volume 61, Number 11-12, November - December 2016, Brandon C. Strubberg, Sarah Bronson, Stephanie Deming, E Nielsen
OncoLog MD Anderson's Report to Physicians (All issues)
- Innovative Trial Investigates Molecular Drivers of Triple-Negative Breast Cancer: A new clinical trial focusing on molecular biomarkers of triple-negative breast cancer (TNBC) is attempting to advance targeted therapy against the deadly disease.
- Smac Mimetics Show Activity against Myelofibrosis: Not all cases of myelofibrosis respond well to ruxolitinib, the only drug approved for this disease. However, early studies indicate that a new class of drugs, Smac mimetics, can achieve a response in some patients with myelofibrosis.
- Urothelial Cancer Subtypes Predict Treatment Response: Subtypes of urothelial cancer identified through gene expression profiling predict which patients are most likely to respond to neoadjuvant …
Oncolog, Volume 61, Number 10, October 2016, Laura L. Russell, Joe Munch, Bryan Tutt, Z Ahmed
Oncolog, Volume 61, Number 10, October 2016, Laura L. Russell, Joe Munch, Bryan Tutt, Z Ahmed
OncoLog MD Anderson's Report to Physicians (All issues)
- Preventing Postoperative Urinary Tract Infections in Cancer Patients: Urinary tract infections (UTIs) increase morbidity, mortality and health care costs and prolong hospitalizations for patients who require urinary catheters-especially those who undergo long, complex surgeries or procedures to treat urological or gynecological cancers. To reduce the incidence of UTIs, clinicians at The University of Texas MD Anderson Cancer Center developed a quality improvement program for surgical patients at the institution.
- Study Offers a Starting Point for Testing Immunotherapy in Rectal Cancer Patients with Deficient DNA Mismatch Repair: A recent study's findings provide a starting point for assessing the efficacy of immunotherapy …